The roles of the human SETMAR (Metnase) protein in illegitimate DNA recombination and non-homologous end joining repair by Tellier, Michael & Chalmers, Ronald
Contents lists available at ScienceDirect
DNA Repair
journal homepage: www.elsevier.com/locate/dnarepair
The roles of the human SETMAR (Metnase) protein in illegitimate DNA
recombination and non-homologous end joining repair
Michael Tellier1, Ronald Chalmers⁎
School of Life Sciences, University of Nottingham, Queen’s Medical Centre, Nottingham, NG7 2UH, UK





DNA double-strand break repair
Metnase
A B S T R A C T
SETMAR is a fusion between a SET-domain methyltransferase gene and a mariner-family transposase gene,
which is speciﬁc to anthropoid primates. However, the ancestral SET gene is present in all other mammals and
birds. SETMAR is reported to be involved in transcriptional regulation and a diverse set of reactions related to
DNA repair. Since the transcriptional eﬀects of SETMAR depend on site-speciﬁc DNA binding, and are perturbed
by inactivating the methyltransferase, we wondered whether we could diﬀerentiate the eﬀects of the SET and
MAR domains in DNA repair assays. We therefore generated several stable U2OS cell lines expressing either wild
type SETMAR or truncation or point mutant variants. We tested these cell lines with in vivo plasmid-based assays
to determine the relevance of the diﬀerent domains and activities of SETMAR in DNA repair. Contrary to pre-
vious reports, we found that wild type SETMAR had little to no eﬀect on the rate of cell division, DNA integration
into the genome or non-homologous end joining. Also contrary to previous reports, we failed to detect any eﬀect
of a strong active-site mutation that should have knocked out the putative nuclease activity of SETMAR.
1. Introduction
SETMAR is an anthropoid primate-speciﬁc fusion between a histone
methyltransferase, which dimethylates histone H3 lysine 36
(H3K36me2), and a domesticated Hsmar1 transposase [1–3]. The
transposase domain is 94% identical to the consensus sequence of the
Hsmar1 transposase consensus sequence but three mutations, including
the DDD to DDN mutation of the catalytic triad, completely abolish the
transposition activity of SETMAR [4–6]. Although some activity, par-
ticularly 5′-end nicking, is recovered in vitro in the presence of DMSO
and Mn2+, it is unlikely to be signiﬁcant under physiological conditions
[4]. Nevertheless, the transposase domain of SETMAR retains its ability
to dimerize and bind transposon ends [2,4,7]. Recently, it was shown
that the expression of thousands of genes is signiﬁcantly altered in
stable human cell lines when they overexpress a modest amount of
SETMAR [7]. Furthermore, the pattern of transcriptional-changes in-
duced by SETMAR expression depended on the methyltransferase and
its site speciﬁc DNA binding to the Hsmar1 transposon ends scattered
throughout the human genome [7]. This supports the hypothesis that
the DNA binding domain of SETMAR serves to target the methylase to a
subset of the Hsmar1 transposon ends dispersed throughout the human
genome [2].
Previous SETMAR overexpression and knockdown experiments
suggested that SETMAR was involved in illegitimate DNA integration
and DNA repair through the non-homologous end joining repair (NHEJ)
pathway [1]. NHEJ is one of the four pathways used by the cell to repair
DNA double-strand breaks (DSBs) and the primary repair pathway
throughout the cell cycle [8]. NHEJ is a template-independent DNA
repair mechanism, which relies on Ku proteins to bind the DNA free
ends, on nucleases, such as Artemis, or polymerases to trim or ﬁll the
DNA overhangs, and on the DNA ligase IV complex to ligate together
the two blunt ends [8].
Although illegitimate DNA integration of transfected plasmid DNA
involves the NHEJ pathway, the precise mechanism remains uncertain
[9,10]. The current model states that the circular plasmid has to be
linearized by a DSB to recruit DNA repair proteins on the plasmid ends
[10]. For genomic integration to happen, one plasmid end needs to be
in the vicinity of a genomic lesion for the NHEJ proteins to use the
linearized plasmid DNA to repair the genomic DSB [10].
One of the diﬃculties in understanding the functions of SETMAR in
DNA repair is that its overexpression produced a response in a number
of diﬀerent assays, suggesting that it was involved in many diﬀerent
aspects of DNA metabolism. For example, its overexpression promoted
classical NHEJ, the random integration of transfected plasmid DNA and
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the restart of stalled replication forks [1,11]. Based on in vitro analysis,
it has been hypothesized that puriﬁed SETMAR could act as an en-
donuclease like Artemis [12,13]. However, SETMAR endonuclease ac-
tivity has only been established in vitro and recent reports question its
relevance in vivo [13,14]. In contrast to Artemis, which promotes both
trimming of DNA overhangs and DNA repair in cell extract assays,
SETMAR did not stimulate DNA repair and only promoted trimming in
one assay.
The SET methylase-domain of SETMAR was shown to interact with
PRPF19, also known as PSO4, which is a protein involved in classical
NHEJ and the spliceosome [15,16]. The interaction with PRPF19 was
predicted to target SETMAR to double strand DNA breaks where the
SET domain could dimethylate the histone H3 lysine 36 of neigh-
bouring nucleosomes [17]. This epigenetic mark would recruit and
stabilize Ku70 and NBS1 to the DNA ends [17]. Two other papers linked
the increase in H3K36me2 following DSBs to the inhibition of KDM2A
and KDM2B, two histone demethylases involved in the removal of
H3K36 methylation [18,19]. However, a recent study using a genome-
wide approach did not detect an increase in H3K36me2 around DSB
sites [20].
A peculiarity of SETMAR is that it is a dimer in solution whereas
almost all mammalian histone methyltransferases function as mono-
mers [21,22]. The only known exception is vSET, a viral histone me-
thyltransferase, which is active only as a dimer [23]. The crystal
structure of the SET domain is also a monomer strengthening the hy-
pothesis that the pre-fusion SET gene was operating as a monomer [24].
The MAR domain enforces the dimerization of SETMAR so even though
the SET domain does not dimerize sensu stricto, the proximity between
the two SET domains could however aﬀect the methyltransferase ac-
tivity or the interactions.
Interestingly, one isoform of SETMAR must have a defective me-
thyltransferase activity because splicing removes the majority of the
SET and post-SET domains in the second exon. This isoform is speciﬁc
to the species where the SET gene is fused to the Hsmar1 transposase
(Fig. 1). The 5′ donor site is present in primates and several other
mammals but the acceptor site is only found in anthropoid primates,
except for the old-world monkeys where a single mutation in their
common ancestor abolishes the acceptor site. The marmosets also lost
the 5′ donor site but another less conserved site is present 20 nucleo-
tides away. This internally deleted isoform is expressed in most human
tissues but at a lower level than the main isoform encoding the active
methyltransferase [25]. This indicates that some SETMAR dimers
would be composed of only one active SET domain and could function
diﬀerently from SETMAR dimers with two SET domains.
To dissect the roles of SETMAR in illegitimate DNA integration and
repair we created several U2OS cell lines expressing isolated SET and
MAR domains, together with various point mutants to diﬀerentiate the
eﬀects of the methyltransferase, DNA binding and the putative nuclease
activity. We found that stable over-expression of SETMAR did not sig-
niﬁcantly alter DNA integration, repair or the rate of cellular pro-
liferation. The most signiﬁcant eﬀect was from overexpression of the
SET domain, which increased plasmid integration and decreased the
rate of plasmid end joining. This raises the possibility that the dimer-
ization of SETMAR imposed by the MAR transposase domain might
block the activities we observe for the isolated SET domain.
2. Materials and methods
2.1. Media and growth conditions
The T-Rex-U2OS cell lines were maintained in complete Dulbecco’s
modiﬁed Eagle’s medium (DMEM, Sigma) supplemented with 10% heat
inactivated Foetal Bovine Serum (FBS), 100 μg/ml of streptomycin,
100 μg/ml of penicillin, and 5 μg/ml of blasticidin (Sigma) at 37 °C with
5% CO2. The medium of T-Rex-U2OS cell lines stably expressing a gene
of interest from an integrated pcDNA4TO plasmid was supplemented
with 400 μg/ml of zeocin (InvivoGen).
Fig. 1. SETMAR second isoform is speciﬁc to
anthropoid primates.
A, The human SETMAR gene encodes two
major isoforms, the full-length protein (isoform
1) and a truncated protein (isoform 2). The
second isoform is methyltransferase deﬁcient
because the majority of the SET and post-SET
domains are removed. Canonical donor site
(DS), lariat branch points (LBP), and acceptor
splicing site (ASS) are present in the second
exon of SETMAR. The top brackets represents
the exon codons. B, Phylogenetic tree of the
second exon of SETMAR in several mammals.
Although the 5′ donor site is absent in the
marmoset [4], it must have appeared before
the emergence of primates because it is present
in several non-primates mammals. The 3′ ac-
ceptor site is speciﬁc to anthropoid primates
except for the old-world monkeys which lost it
owing to a single point mutation.
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2.2. Plasmids
An artiﬁcial codon-optimized version of SETMAR was synthesized
by Gene Art (Thermo Fischer) and cloned into pcDNA4TO at the EcoRI/
NotI restriction sites to produce pRC1702 (SM). Three Flag tags were
cloned into pcDNA4TO between EcoRI and XbaI to produce pRC1703.
The artiﬁcial codon-optimized version of SETMAR was cloned into
pRC1703 at the HindIII/EcoRI restriction sites to produce pRC1704
(SMF). The truncated versions of SETMAR were produced by PCR and
cloned into pRC1703 at the HindIII/EcoRI restriction sites to construct
SETF (pRC1705) and MARF (pRC1706). SETF-N210A (pRC1707) and
SMF-N210A (pRC1708), -R432A (pRC1709) and -D483A (pRC1710)
single point mutant were produced by PCR on pRC1705 for SETF and
pRC1704 for SMF. For the plasmid integration assay, pRC1714 was
constructed by cloning a neomycin resistance gene into pBluescript SKII
+ (Agilent) at the BamHI restriction site. Plasmid sequences are given
in Supplemental Table 1.
2.3. Stable transfection of T-Rex-U2OS cells
For each transfection, 2.5× 105 cells were seeded in a 6-well plate
and grown overnight in DMEM supplemented with 10% FBS. The
plasmids were transfected using Lipofectamine 2000 (Invitrogen), fol-
lowing manufacturer’s instruction. After 24 h, a quarter of the cells
were transferred to 100mm dishes and the medium supplemented with
400 μg/ml of zeocin (InvivoGen). After 2 weeks of selection, single foci
were picked and grown in a 24-well plate. The expression of the gene of
interest was veriﬁed in each cell line by inducing the PCMV promoter
with doxycycline at a ﬁnal concentration of 1 μg/ml for 24 h. The list of
cell lines used in this study is presented in Table 1.
2.4. Western blotting
Whole cell extracts were harvested from cultures at ˜90% con-
ﬂuency in six-well plates. Brieﬂy, cells were washed twice with ice-cold
PBS then pelleted for 5min at 3000 x g at 4 °C. Samples were re-
suspended in 100 μl of Radio ImmunoPrecipitation Assay (RIPA) buﬀer
(10mM Tris−HCl pH8.0, 150mM NaCl, 1 mM EDTA, 0.1% SDS, 1%
Triton X-100, 0.1% sodium deoxycholate) with freshly added protease
inhibitor cocktail (Roche Applied Science) and incubated on ice for
30min with a vortexing every 10min. Cell lysates were centrifuged for
15min at 14,000 x g at 4 °C and the protein in the supernatants was
quantiﬁed by the Bradford assay.
For each western blot, 20 μg of cell-extract protein was mixed with
2X SDS loading buﬀer, boiled for 5min, and electrophoresed on a 10%
SDS-PAGE gel. Proteins were transferred to a polyvinylidene diﬂuoride
(PVDF) membrane, which was blocked in 5% milk or BSA (Roche) and
incubated with speciﬁc primary antibodies at 4 °C overnight. After
washing, membranes were incubated with horseradish peroxidase
(HRP)-conjugated secondary antibodies for one hour at room tem-
perature, washed, and signals were detected with the ECL system
(Promega) and Fuji medical X-ray ﬁlm (Fujiﬁlm).
The following antibodies were used: anti-beta Tubulin (rabbit
polyclonal IgG, 1:500 dilution, ab6046, Abcam), anti-Hsmar1 antibody
(goat polyclonal, 1:500 dilution, ab3823, Abcam), anti-Flag (rabbit,
1:500 dilution, F7425, Sigma). The secondary antibodies were horse-
radish peroxidase-conjugated anti-goat (rabbit polyclonal, 1:5000 di-
lution, ab6741, Abcam) and anti-rabbit (goat polyclonal, 1:5000-
1:10000, ab6721, Abcam).
2.5. Transcriptome acquisition and analysis
Total RNAs were isolated from cells grown to ∼80% conﬂuency in
six-well plate with the High Pure RNA isolation kit (Roche Applied
Science), following manufacturer's instructions. The samples were
quantiﬁed with a Nanodrop Spectrophotometer and their quality ver-
iﬁed with a Bioanalyzer (Agilent). Only samples with a RIN number>9
were used. Approximately 10 μg of total RNA was used to enrich for
mRNA using two rounds of enrichment with Dynabeads Oligo(dT)25
(Life tech, 61,005). Solid whole transcriptome libraries were made ac-
cording to the Solid Total RNASeq protocol (Life tech, 4,445,374) and
sequenced on an ABi SOLiD 5500xl analyzer according to the manu-
facturer's instructions to generate 50 bp reads in colour space. RNA-seq
was performed on biological duplicates. The RNA-seq colour-space
reads were initially processed using The LifeTechnologies LifeScope
(v2.5.1) Whole Transcriptome Pipeline. Reads were ﬁrst ﬁltered against
rRNA, tRNA, and sequencing contaminants and then mapped to the
Homo sapiens GRCh37 hg19 genome assembly from Ensembl. For cal-
culating the reads per kilobase of transcript per million mapped reads
(RPKM) values, exons were extracted in R with the GenomicFeatures
package and grouped by ‘gene’. Expression at the transcript level was
quantiﬁed with HTSeq version 0.6.1 and diﬀerential expression was
calculated with the DESeq2 software version 3.2, keeping only the
genes with a fold change<−2 or> 2 and an adjusted P-value of 0.05.
Sequencing data have been deposited in GEO under accession number
GSE129870.
2.6. Growth rate
On day 0, 2×104 cells were seeded in eight 6 cm dishes for each
cell line and one dish was counted every day for eight days using a
hemocytometer. A p-value less than or equal to 0.01 was considered as
statistically signiﬁcant.
Table 1
Mammalian cell lines used in this study.
Cell line Description
T-Rex-U2OS Human osteosarcoma cell line stably expressing the tetracycline repressor protein.
T-Rex-U2OS-TO (U2OS) Parental line. T-Rex-U2OS cell line stably transfected with an empty pcDNA4TO.
T-Rex-U2OS-SETMAR T-Rex-U2OS cell line stably expressing SETMAR.
T-Rex-U2OS-TO-Flag (U2OS-F) Parental line. T-Rex-U2OS cell line stably transfected with an empty pcDNA4TO-Flag.
T-Rex-U2OS-SET-Flag T-Rex-U2OS cell line stably expressing the Flag-tagged exons 1 and 2 of SETMAR (= SET domain).
T-Rex-U2OS-SET-Flag N210A T-Rex-U2OS cell line stably expressing the Flag-tagged exons 1 and 2 of SETMAR (= SET domain) with the mutation N210A abolishing the
methyltransferase activity of SET.
T-Rex-U2OS-MAR-Flag T-Rex-U2OS cell line stably expressing the Flag-tagged exon 3 of SETMAR (= MAR domain).
T-Rex-U2OS-SETMAR-Flag T-Rex-U2OS cell line stably expressing a Flag-tagged SETMAR.
T-Rex-U2OS-SETMAR N210A-Flag T-Rex-U2OS cell line stably expressing a Flag-tagged SETMAR with the mutation N210A abolishing the methyltransferase activity of
SETMAR.
T-Rex-U2OS-SETMAR R432A-Flag T-Rex-U2OS cell line stably expressing a Flag-tagged SETMAR with the mutation R432A decreasing the aﬃnity of SETMAR for the
transposon end.
T-Rex-U2OS-SETMAR D483A-Flag T-Rex-U2OS cell line stably expressing a Flag-tagged SETMAR with the D483A mutation abolishing the catalytic activity of transposase
domain of SETMAR.
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2.7. Illegitimate DNA integration assay
For integration assays in the Flag-tagged T-Rex-U2OS cell lines,
8× 105 cells were seeded onto 6-well plates with 2.5 μg of circular or
linearized pRC1712 and 5 μl of Lipofectamine 2000 (Invitrogen).
Twenty-four hours later, cells were trypsinized and 5×104 cells of
each transfection were seeded onto 10 cm dishes in medium containing
800 μg/ml of G418 (Sigma). For integration assays in U2OS and SM3,
105 cells were seeded onto 6-well plates with 2 μg of circular pRC1712
and 4 μl of Lipofectamine 2000 (Invitrogen). Twenty-four hours later,
cells were trypsinized and the cells of each transfection were seeded
onto 10 cm dishes in medium containing 800 μg/ml of G418 (Sigma).
After two weeks of selection, surviving foci were ﬁxed for 15min with
10% formaldehyde in PBS, stained for 30min with methylene blue
buﬀer (1% methylene blue, 70% ethanol), washed with water, air dried,
and photographed. The transfection eﬃciency was tested by trans-
fecting a pEGFP plasmid. After 24 h, the live cells were observed using a
Carl Zeiss Axiovert S100 TV Inverted Microscope with an HBO 100 il-
luminator. The transfection eﬃciency was found to be similar between
the diﬀerent cell lines. A p-value less than or equal to 0.01 was con-
sidered as statistically signiﬁcant.
2.8. Non-homologous end-joining assay and FACS analyses
Prior to transfection, the pEGFP-Pem1-Ad2 plasmid was digested
overnight with HindIII or I-SceI. The digestion reactions were heat-in-
activated and column-puriﬁed before being co-transfected with a pRFP
plasmid as a control for transfection eﬃciency. A day before transfec-
tion, 8×105 cells were seeded in 60mm dishes to obtain a ˜70%
conﬂuency on the transfection day. Transfections were performed with
3 μg of linear pEGFP-Pem1-Ad2, 3 μg of pRFP and 14 μl of
Lipofectamine 2000 (Invitrogen), according to manufacturer’s instruc-
tions. After 24 h, green (GFP) and red (RFP) ﬂuorescence was measured
by ﬂuorescence-activated ﬂow cytometry (FACS). For FACS analysis,
cells were harvested with Accutase (Sigma), washed once in 1X PBS and
ﬁxed in 2% formaldehyde (Sigma). FACS analysis was performed on a
Coulter FC500 (Beckman Coulter) and data analysed using Weasel
software v3.0.2. The numbers of repaired events are reported as the
ratio of green and red positive cells over the total number of red po-
sitive cells. This ratio normalizes the numbers of repaired events to the
transfection eﬃciency. The values for all the cell lines are reported as a
percent of the control cell lines. A p-value less than or equal to 0.01 was
considered as statistically signiﬁcant.
3. Results
3.1. SETMAR overexpression does not promote U2OS cell proliferation
It was previously reported that SETMAR overexpression increased
the growth rate of the HEK293 and HEK293 T cell lines [26]. Con-
versely, SETMAR depletion by RNA interference or CRISPR/Cas9
knock-out decreased the growth rate of THP-1 and DLD-1 cancer cells,
respectively [27,28]. Furthermore, we previously demonstrated that
modest, stable, overexpression of SETMAR in a U2OS cell line sig-
niﬁcantly changed the expression of a large set of genes, and that this
depended on the DNA binding and methyltransferase activities [7].
However, we did not detect an enrichment for genes involved in the cell
cycle [7]. To determine whether altering SETMAR expression level also
aﬀects the growth rate of the U2OS cell line, we tested three stable T-
Rex-U2OS cell lines overexpressing SETMAR at diﬀerent levels, to-
gether with one cell line expressing the SET domain only and a parental
cell line with an empty expression vector integrated in its genome
(Fig. 2A). The expression level of the SET domain or SETMAR was
determined by western blotting using an anti-Flag antibody. The
growth rate was determined by counting the number of cells across a
period of eight days (Fig. 2B). Contrary to previous reports, we
observed a small but signiﬁcant decrease in cell proliferation for most
of the cell lines overexpressing SET or SETMAR after 7 days.
3.2. Eﬀects of expressing SETMAR mutants and individual domains
To improve our understanding of the roles of SETMAR in illegiti-
mate DNA integration and the NHEJ pathway, we produced several
U2OS cell lines stably overexpressing wild type, truncated or mutant
versions of SETMAR (Fig. 3A and Table 2). Previously, we found that
transient transfection of a SETMAR expression vector gave 2500-fold
overexpression [7]. We therefore established stable cell lines to obtain
more modest expression levels. We relied on an overexpression strategy
rather than knockdown because the aﬃnity of the commercial anti-
bodies was too low to detect expression of endogenous SETMAR in the
U2OS cell line. To interpret the experiments we must recall that the
puriﬁed transposase domain exists as a dimer and that this is probably
also the multimeric state of SETMAR in vivo [29]. The concentration of
endogenous SETMAR in the U2OS cell line is relatively low, with less
than 500 molecules per cell [30]. Since the exogenous proteins were
expressed to a much higher level, most of the multimers will be
homogeneous. However, the endogenous SETMAR will produce a low
level of mixed multimers by random assortment. It is therefore im-
portant to keep in mind that the activity of the endogenous SETMAR
may be inﬂuenced by the overexpression of the mutant subunits. The
exogenous expression level of each cell line was determined by western
blotting using anti-Hsmar1 transposase and anti-Flag antibodies
(Fig. 3B). An anti-Flag antibody was used for the cell lines containing an
F (for Flag-tag) in their names. SM2 and 3 cell lines overexpress un-
tagged versions of SETMAR so their expression levels were determined
using an antibody against the last nine amino acids of SETMAR.
The two control cell lines, U2OS and U2OS-F, express only the en-
dogenous SETMAR. We used four cell lines overexpressing wild type
SETMAR at medium (SMF2 and SMF3), high (SM2) or very high levels
(SM3). The relative levels of SETMAR expression in SMF3, SM2, and
SM3 were ﬁrst conﬁrmed by western blotting with the anti-Hsmar1
transposase antibody (Supplementary Fig. 1). A signal was observed
only for SM2 and SM3, indicating that SMF3 expresses SETMAR at a
lower level than SM2 and SM3. We also performed RNA-seq on the
Fig. 2. SETMAR overexpression does not promote U2OS cell proliferation.
A, Western blot for the Flag-tagged SETMAR in the U2OS, SETF and SMF cell
lines. The western blot was performed with anti-Flag and anti-β-tubulin anti-
bodies. B, The growth rate of U2OS, SETF and SMF cell lines. On day 0,
2.0× 104 cells were seeded in eight dishes and one dish was counted every day
for eight days. Average ± S.E.M. of 3–5 biological replicates. Statistical test: t-
test with Holm-Sidak correction, ** p-value< 0.01, *** p –value< 0.001.
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U2OS, SM2, and SM3 cell lines and compared the expression levels to
the RNA-seq experiments that we previously conducted in the SMF3 cell
line (Table 3) [7]. Since we used two diﬀerent RNA-seq methods
(SOLiD for the SM cell lines and Illumina for the SMF3 cell line), we
normalized the ectopic SETMAR expression to β-tubulin. Consistent
with the result of the western blot, we found the normalized SETMAR
expression to be three times lower in SMF3 than in SM2. Of note, in the
SM3 cell line exogenous SETMAR is the 32nd most expressed gene,
compared to the endogenous SETMAR which is the 8,377th most ex-
pressed gene.
In the SETF1 and SETF2 cell lines, the SET domain is expressed at
low and medium-to-high levels, respectively. In the MAR cell line, the
transposase domain is expressed at medium-to-high level. We also
created three point mutations in key functional residues. The N210A
mutation, which is located in the key NHSC motif of the SET domain,
abolishes the methyltransferase activity of SETMAR [7]. To investigate
any eﬀect of SETMAR binding to genomic Hsmar1 transposon ends
(inverted terminal repeat, ITR), we introduced the R432A mutation,
which decreases the aﬃnity of SETMAR for the Hsmar1 transposon
ends [29,31]. To test the requirement of SETMAR’s putative nuclease
activity, we introduced the D483A mutation. This substitutes the ﬁrst D
in the DDD triad of amino acids that coordinate the catalytic metal ions
in the active site [13,29]. Although some substitutions of the last D
residue may be tolerated, the ﬁrst D coordinates both metal ions in the
active site and is absolutely required for activity in the RNase H family
Fig. 3. U2OS cell lines used in the in vivo DNA repair assay.
A, A schematic representation of SETMAR (pRC1702 and
pRC1704), SET (pRC1705) and MAR (pRC1706) and the lo-
cations of the diﬀerent mutations (pRC1707 to pRC1710). B, A
western blot for the Flag-tagged SETMAR in the U2OS, SM,
SETF, MARF and SMF cell lines. The western blot was per-
formed with anti-Hsmar1 transposase (SETMAR), anti-Flag
(SETMAR-Flag, SET / MAR-Flag) and anti-β-tubulin anti-
bodies. The cell lines are described in Table 2. U2OS, U2OSF:
parental lines; SM: SETMAR; SMF: SETMAR-Flag; SETF: SET
domain-Flag; MARF: MAR domain-Flag.
Table 2
U2OS cell lines used in the in vivo DNA repair assay.
Full name Abbreviation Expression level Comparison to SMF3 cell line on western blots
T-Rex-U2OS-TO (parental line) U2OS Endogenous level /
T-Rex-U2OS-SETMAR SM2 High Visible with anti-Hsmar1 transposase antibody, not SMF3
SM3 Very high Visible with anti-Hsmar1 transposase antibody, not SMF3
T-Rex-U2OS-TO-Flag (parental line) U2OS-F Endogenous level /
T-Rex-U2OS-SET-Flag SETF1 Low Lower than SMF3 with anti-Flag antibody
SETF2 Medium/High Higher than SMF3 with anti-Flag antibody
T-Rex-U2OS-SET-N210A- Flag SETF-N210A Low Lower than SMF3 with anti-Flag antibody
T-Rex-U2OS-MAR-Flag MARF Medium/High Higher than SMF3 with anti-Flag antibody
T-Rex-U2OS-SETMAR-Flag SMF1 Medium Similar to SMF3 with anti-Flag antibody
SMF2 Medium Similar to SMF3 with anti-Flag antibody
SMF3 Medium /
T-Rex-U2OS-SETMAR-N210A-Flag SMF-N210A Medium Similar to SMF3 with anti-Flag antibody
T-Rex-U2OS-SETMAR R432A-Flag SMF-R432A Low Lower than SMF3 with anti-Flag antibody
T-Rex-U2OS-SETMAR D483A-Flag SMF-D483A Low/Medium Lower than SMF3 with anti-Flag antibody
Table 3
SETMAR and β-tubulin expression levels in the U2OS cell lines expressing full-
length SETMAR.
Cell line SETMAR (RPKM/FPKM) TUBB (RPKM/FPKM) % of TUBB
U2OS 4 336 1
SM2 193 283 68
SM3 410 248 166
U2OS-F 5 976 1
SMF3 176 818 22
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of nucleases [32].
3.3. The SET and MAR domains but not SETMAR promote DNA integration
SETMAR was previously reported to promote the illegitimate in-
tegration of plasmid DNA into the genome [1]. We used the diﬀerent
Flag-tagged SETMAR domains and mutants to gain a better under-
standing of DNA integration. For a plasmid to be integrated, two events
are thought to be required (Fig. 4A). First, the plasmid must be line-
arized by a DSB and then it must be recruited by NHEJ proteins that are
in the process of dealing with a chromosomal double strand break [10].
However, illegitimate integration is only one of the three possible
outcomes for a linearized plasmid because it can also be re-circularized
or degraded (Fig. 4A). We determined the rate of illegitimate plasmid
integration by transfecting a plasmid encoding a neomycin resistance
gene before challenging the cells with G418 for two weeks. Cells in
which the plasmid has been integrated into the genome could develop
into foci. The foci were counted after staining with methylene blue.
To determine whether the topology of the plasmid inﬂuences its
integration frequency, we transfected a circular or linear version of the
same plasmid in the control cell line U2OS-F. We observed a ˜3-fold
decrease in the integration of the linearized form compared to the
circular (Supplementary Fig. 2). We therefore used the circular plasmid
for all further experiments with SETMAR and its derivatives.
We measured the rate of plasmid integration with cell lines ex-
pressing SETMAR and a selection of mutant derivatives including its
individual domains (Fig. 4B and C). Since the respective genes are in-
tegrated in the genome, the protein expression levels are not identical
and a strict comparison between the cell lines is not always possible
(Table 2,3). Nevertheless, since the cell lines are clonal, and each cell in
the respective population has the same expression level, this strategy is
better than transient transfection where there is a distribution of ex-
pression-cassette copy-numbers. In three cell lines expressing wild type
SETMAR at medium to very high levels we detected no signiﬁcant
diﬀerence in the plasmid integration rate (Fig. 4B and C). There were
marginal increases in integration rate with the MAR domain and the
SETMAR N210A mutant. The largest and most signiﬁcant increase was
for the cell line expressing a medium to high level of the SET domain.
3.4. The SET and MAR domains have an opposite eﬀect on plasmid end-
joining
To gain a better understanding of SETMAR functions in the NHEJ
pathway, we used an established in vivo DNA repair assay [33]. The
assay is based on two plasmids, one encoding the reporter gene (pEGFP)
and the other serving as a transfection control (pRFP). The reporter
plasmid encodes an EGFP gene interrupted by a 2.4 kb intron derived
from the rat Pem1 gene. An exon from the adenovirus (Ad2) has been
integrated in the intron, which abolishes the GFP activity (Fig. 5A). The
Ad2 exon is ﬂanked by HindIII and I-SceI recognition sites. Cleavage
with HindIII or I-SceI yields compatible or incompatible ends, respec-
tively (Fig. 5B). These two types of ends require diﬀerent steps for re-
pair. Compatible ends can be ligated directly, while incompatible ends
with 3′-overhangs have to be trimmed before ligation. The repair of the
linearized plasmid by the NHEJ pathway restores the GFP ORF
(Fig. 5C). The repair events were detected by ﬂow cytometry measuring
at least 10,000 cells per assay. The repair eﬃciency was calculated as
the ratio of green and red cells over the total number of red cells, thus
normalizing the transfection eﬃciency between cell lines.
To normalize between the biological replicates, we calculated for
each replicate the ratio of the repair eﬃciency of each cell line relative
to their respective control cell lines. The average ratio from three in-
dependent experiments is presented in Fig. 5D. The SM2 and 3 cell lines
were compared to the U2OS control cell line, whereas the remaining
cell lines were compared to U2OS-F to take into account any possible
eﬀect of the Flag tag. Unsurprisingly, there was no signiﬁcant diﬀerence
in the repair eﬃciency of both types of ends between the two control
cell lines (Supplementary Fig. 3). In agreement with previously pub-
lished results for this assay, we observe that in most cell lines in-
compatible ends were repaired about 10% less eﬃciently than com-
patible ends [33]. Presumably this reﬂects the necessity of processing
the DNA overhangs before the plasmid ends can be ligated.
The overexpression of SETMAR, irrespective of the level, or of
SETMAR mutants did not promote the repair of either compatible or
incompatible ends (Fig. 5D). This contradicts previous reports of in vivo
experiments [1,34] but conﬁrms later results in cell-free extracts [13].
However, with medium-to-high expression of the SET domain we de-
tected a decrease of about 20% in the repair of both compatible and
incompatible ends. In contrast, medium overexpression of the MAR
domain increased the repair eﬃciency of both types of ends by ˜20%
compared to the control cell line.
4. Discussion
A set of previous reports has claimed a direct role for SETMAR in
diverse aspects of DNA metabolism [1,11,12,15–17,26,27,29,34–38].
However, subsequent studies have challenged some of these claims to
various extents [4,5,7,13,14,28].
One proposition was that SETMAR could be involved in DNA repair
through the NHEJ pathway. Here we have pursued this question by
investigating the relative contributions to NHEJ of SETMAR, the iso-
lated SET and MAR domains, and, by way of mutagenesis, the con-
tributions of the methyltransferase, the ITR binding and the nuclease
activities. We found that expression of the SET domain, and to a lesser
extent the MAR domain, but not wild type SETMAR, have a mild eﬀect
on DNA integration and end-joining. In addition, we found that the
putative nuclease activity of SETMAR does not seem to be important for
these processes in vivo.
Previous reports have linked SETMAR over-expression or knock-
down/knock-out to increased or decreased proliferation, respectively,
in HEK293, THP1, and DLD-1 cell lines [26–28]. We did not detect this
eﬀect in the U2OS cell line (Fig. 1B). Indeed, a modest overexpression
of SETMAR or the SET domain reduced the growth rate slightly after six
to seven days. Furthermore, in a previous transcriptomic study, and in
the current RNA-seq measurements performed on the SM2 and SM3 cell
lines, we did not detect an enrichment in cell-cycle genes in the set of
genes diﬀerentially expressed upon SETMAR overexpression (Supple-
mentary Table 2) [7].
Other previous reports on the function of SETMAR in NHEJ claimed
two speciﬁc roles for the SET and the MAR domains [17,30]. Firstly,
they proposed that the SET domain dimethylates H3K36 of nucleo-
somes near DSBs. This epigenetic mark is thought to recruit and
Fig. 4. The SET and MAR domains but not SETMAR promote DNA integration.
A, A schematic representation of the integration assay. Cells are transfected with a circular plasmid (pRC1714), which encodes a neomycin resistance gene. For
integration to occur through the NHEJ pathway, the plasmid must be linearized by a DSB and a plasmid free end has to be in close vicinity of a genomic DSB. The
linearized plasmid can also be re-circularize or be degraded. Following G418 treatment for two weeks, cells in which the G418 marker has been integrated into the
genome form foci which can be detected by methylene blue staining. B, Representative pictures of integration plates. The expression level is indicated between
brackets and is derived from Tables 2 and 3. The integration rate for each cell line is indicated below each picture. C, DNA integration eﬃciency of a circular plasmid
encoding a neomycin resistance gene in the diﬀerent cell lines relative to the parental cell line, U2OS or U2OS-F. Average ± S.E.M. of 3 biological replicates.
Statistical test: one-way ANOVA Dunnett’s multiple comparisons test, ** p-value<0.01, **** p-value< 0.0001.
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stabilize the binding of Ku70 and NBS1 to the DNA ends [17]. Secondly,
they proposed that the MAR domain trims DNA overhangs before other
NHEJ proteins mediated ligation of the ends [12]. It has also been
claimed that SETMAR activity is regulated by several interactions with
other proteins involved in the NHEJ such as PRPF19 and DNA ligase IV
[15,16]. The only conﬁrmed direct interaction was between the SET
domain and PRPF19 and was hypothesized to promote the recruitment
of SETMAR to DSBs [15]. Based on our transcriptomic experiments in
U2OS cell lines expressing SETMAR or SETMAR N210A, we did not
observe any enrichment for DNA repair genes in the set of diﬀerentially
expressed genes, indicating that SETMAR is unlikely to act in NHEJ
through regulation of gene expression (Supplementary Table 2) [7].
In our in vivo assays, overexpression of the wild type SETMAR did
not aﬀect DNA end-joining or integration. However, we found that
medium overexpression of the SET domain decreases DNA end-joining
eﬃciency and increases illegitimate DNA integration (Fig. 4B and 5D,
compare SETF2 to SETF1 and the control). In our assays, both DNA end-
joining and integration are supposed to be dependent on the NHEJ
Fig. 5. The SET and MAR domains have an opposite eﬀect on DNA repair.
A, The reporter plasmid, pEGFP-Pem1-Ad2, is composed of a GFP cassette ﬂanked by a PCMV promoter and a SV40 poly(A) sequence. The eGFP coding sequence is
interrupted by a 2.4 kb intron containing an adenovirus exon (Ad). The Ad exon is ﬂanked by HindIII and I-SceI restriction sites. The donor (DS) and acceptor (AS)
splicing sites are shown. B, HindIII and I-SceI restriction sites are respectively composed of a palindromic 6-bp and a non-palindromic 18-bp sequence. Digestion of the
reporter by HindIII or I-SceI generates respectively compatible and incompatible ends. C, The presence of the Ad exon in the eGFP ORF inactivates the eGFP activity
thus making the cell eGFP negative. Removal of the Ad exon by HindIII or I-SceI followed by a successful intracellular repair will restore eGFP expression, which is
then quantiﬁed by ﬂow cytometry. The assay was adapted from ref. [33]. D, The frequency of end joining in the indicated cell lines compared to the parental U2OS
and U2OS-F cell lines was determined by ﬂow cytometry. Average ± S.E.M. of 3 biological replicates. Statistical test: one-way ANOVA Dunnett’s multiple com-
parisons test, ** p-value<0.01, *** p-value<0.001, **** p-value<0.0001.
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pathway, consistent with a role for the ancestral SET gene in this
pathway. However, the mechanism by which the SET domain favours
DNA integration over DNA end-joining is unclear. The decrease in re-
circularization with both compatible and incompatible ends found in
the DNA end-joining assay could delay the re-circularization of plas-
mids, increasing the window of opportunity for a plasmid end to be in
the vicinity of a genomic end and therefore promoting its genomic in-
tegration.
The clearest result of our assays was that overexpression of the MAR
domain stimulates both DNA repair and integration (Fig. 4B and 5D).
Amongst the set of previous reports proposing a direct role for SETMAR
in diverse aspects of DNA repair there were claims that the MAR do-
main could bind DNA ends and its nuclease activity could trim the
overhangs [12,13]. This was at odds with our own work in which we
failed to detect any nuclease activity of the puriﬁed MAR domain using
an extremely sensitive assay with a 32P-labelled substrate [4]. We de-
tected faint nuclease activity if the DDN triad in the active site was
mutated back to the wild type DDD or if the reaction was supplemented
with Mn2+ instead of Mg2+. Since Mn2+ is not present in signiﬁcant
quantities in vivo we were sceptical about a nucleolytic role for
SETMAR. Furthermore, if the MAR domain has a trimming activity, we
would expect to observe a larger increase in the repair of incompatible
ends versus compatible ends in the present experiments. In fact, the
increase in the DNA end-joining is similar for both types of ends, which
does not support a trimming activity (Fig. 5D). Also, overexpression of
SETMAR D483A mutant, which should abolish any remaining catalytic
activity of the MAR domain, does not decrease DNA end-joining
(Fig. 5D). In fact, we observe no signiﬁcant change on DNA integration
and DNA end-joining (Figs. 4B and 5 D). This seems to indicate that the
MAR domain of SETMAR does not trim DNA overhangs in vivo.
Unsurprisingly, the ITR binding activity of SETMAR is not required
for DNA end-joining and integration (Figs. 4B and 5 D). In contrast, a
medium overexpression of the methyltransferase defective mutant,
SETMAR N210A, does not aﬀect DNA end-joining but increases DNA
integration, whereas overexpression of the wild type SETMAR does not
aﬀect either of these processes (Figs. 4B and 5 D). The absence of an
eﬀect of the N210A mutation in the SET domain is likely due to its low
level of expression. Its level of expression is similar to SETF1, which is
too low to aﬀect DNA end-joining and integration in our assays. How-
ever, it remains unclear whether this eﬀect on NHEJ of SETMAR N210A
is mediated by a direct methylation of factors involved in NHEJ or a
consequence of a decreased bulk H3K36me2 level in the SETMAR
N210A cells [7]. Two studies, which also observed an increase in
H3K36me2 at DSB sites, linked the increase to the removal of histone
demethylases from the chromatin rather than active methylation
[18,19]. In contrast, a recent study did not ﬁnd any increase in
H3K36me2 at a DSB site but found instead an increase in H3K36me3
[20]. In addition to a decreased H3K36me2 level, we also observed a
decrease of H3K36me3 at some genomic positions, possibly because of
a decrease in the level of H3K36me2, which is required by SETD2 for
adding the third methyl group [7]. The decreased NHEJ activity with
SETMAR N210A could therefore be owing to a reduced cellular level of
H3K36me2/me3, which could aﬀect the eﬃciency of repair by the
NHEJ pathway.
An interesting question is why the SET and the MAR domains have
an eﬀect on DNA end-joining and integration but not the wild type
SETMAR? One possibility is that the functions of the SET domain in
NHEJ are blocked by the dimerization of the protein mediated by the
MAR domain.
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